Tips & tricks to get the most out of Windows10

Open in browser

Windows 10: everything you need to know about Microsoft´s new OS

10 tips for customizing Windows 10 and...

Microsoft's latest and greatest operating system Windows 10 launched in 190 countries this week and Softonic brings you the best tips to make the most out of it. While the upgrade to Windows 10 should be smooth sailing, as with any new operating system you will have to tweak it to get it working just the... Read more

Windows 10 still not downloading? We have the solution

There is an unofficial way to force Windows Update to start downloading Windows 10. It has gone viral, and already many users have been able...

How to run old software on Windows 10

Every time there's a new version of Windows, people wonder if their current software will continue to work. The answer is a little complex, but...

How to get Windows 10 when the upgrade button is missing

Windows 10 come out on July 29. But, even more exciting than that, Microsoft's new operating system will be free for nearly all users of Windows...

The Best 24 Apps for Windows 10

One of Windows 10's biggest features as an operating system is its flexibility moving between devices. Whether you are on your home computer,...

How to get the most out of Cortana, the Windows 10 virtual assistant

Windows 10's new assistant, Cortana has arrived and we are here to see exactly what she is capable of doing. To do this, we have split her functions...

How to upgrade safely to Windows 10 on your PC or smartphone

Windows 10 will be available on July 29th for all compatible devices. You may have seen a message on your PC asking if you wish to reserve it...

Softonic Turbo Booster

Clean unnecessary files from the memory of your Android and boost its performance.

Softonic Newsletter for dbtech.hp.alert@blogger.com. To cancel your subscription to this newsletter, click here.
If you would like to contact Softonic, please do so here.
Softonic is a registered trademark of Softonic International, S.A. in Europe and other countries. All rights reserved. © 2014. CIF: A-62134341. C/ Rosselló i Porcel, 21, Barcelona, 08016, Spain.

Comments

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition. In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates. So, why is this approval so important? First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com . Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead. CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday. It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly? The answer isn't clear yet. We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct. But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side

DBTECH

Search This Blog